These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibitory effect of beta-glucans on zymosan-mediated hydrogen peroxide production by murine peritoneal macrophages in vitro. Adachi Y; Ohno N; Yadomae T Biol Pharm Bull; 1993 May; 16(5):462-7. PubMed ID: 8364492 [TBL] [Abstract][Full Text] [Related]
3. Effect of beta-glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Ohno N; Egawa Y; Hashimoto T; Adachi Y; Yadomae T Biol Pharm Bull; 1996 Apr; 19(4):608-12. PubMed ID: 8860968 [TBL] [Abstract][Full Text] [Related]
4. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. Czop JK; Austen KF J Immunol; 1985 Apr; 134(4):2588-93. PubMed ID: 2579146 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of (1-->3)-beta-D-glucans in the induction of cytokine production from macrophages, in vitro. Okazaki M; Adachi Y; Ohno N; Yadomae T Biol Pharm Bull; 1995 Oct; 18(10):1320-7. PubMed ID: 8593430 [TBL] [Abstract][Full Text] [Related]
6. Phagocytosis of unopsonized zymosan particles by trypsin-sensitive and beta-glucan-inhibitable receptors on bone marrow-derived murine macrophages. Kadish JL; Choi CC; Czop JK Immunol Res; 1986; 5(2):129-38. PubMed ID: 3020136 [TBL] [Abstract][Full Text] [Related]
7. Phagocytosis of beta-1,3-D-glucan-derivatized microbeads by mouse peritoneal macrophages involves three different receptors. Konopski Z; Rasmussen LT; Seljelid R; Eskeland T Scand J Immunol; 1991 Mar; 33(3):297-306. PubMed ID: 1849314 [TBL] [Abstract][Full Text] [Related]
8. Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan. Sakurai T; Kaise T; Yadomae T; Matsubara C Eur J Pharmacol; 1997 Sep; 334(2-3):255-63. PubMed ID: 9369356 [TBL] [Abstract][Full Text] [Related]
9. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. Czop JK; Austen KF J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195 [TBL] [Abstract][Full Text] [Related]
10. Oxidative degradation of an antitumor (1-3)-beta-D-glucan, grifolan. Nono I; Ohno N; Masuda A; Oikawa S; Yadomae T J Pharmacobiodyn; 1991 Jan; 14(1):9-19. PubMed ID: 1907324 [TBL] [Abstract][Full Text] [Related]
12. Effects of particulate and soluble (1-3)-beta-glucans on Ca2+ influx in NR8383 alveolar macrophages. Mörk AC; Helmke RJ; Martinez JR; Michalek MT; Patchen ML; Zhang GH Immunopharmacology; 1998 Jul; 40(1):77-89. PubMed ID: 9776481 [TBL] [Abstract][Full Text] [Related]
13. Laminarin, a soluble beta-glucan, inhibits macrophage phagocytosis of zymosan but has no effect on lipopolysaccharide mediated augmentation of phagocytosis. Fuentes AL; Millis L; Sigola LB Int Immunopharmacol; 2011 Nov; 11(11):1939-45. PubMed ID: 21856445 [TBL] [Abstract][Full Text] [Related]
14. Inactivation of (1-->3)-beta-D-glucan in mice. Miura T; Ohno N; Suda M; Miura NN; Shimada S; Yadomae T Biol Pharm Bull; 1995 Dec; 18(12):1797-1801. PubMed ID: 8787813 [TBL] [Abstract][Full Text] [Related]
15. A beta-glucan inhibitable zymosan receptor on channel catfish neutrophils. Ainsworth AJ Vet Immunol Immunopathol; 1994 May; 41(1-2):141-52. PubMed ID: 8066990 [TBL] [Abstract][Full Text] [Related]
16. Immunopharmacological and immunotoxicological activities of a water-soluble (1-->3)-beta-D-glucan, CSBG from Candida spp. Tokunaka K; Ohno N; Adachi Y; Tanaka S; Tamura H; Yadomae T Int J Immunopharmacol; 2000 May; 22(5):383-94. PubMed ID: 10708886 [TBL] [Abstract][Full Text] [Related]
17. Effect of orally administered beta-glucan on macrophage function in mice. Suzuki I; Tanaka H; Kinoshita A; Oikawa S; Osawa M; Yadomae T Int J Immunopharmacol; 1990; 12(6):675-84. PubMed ID: 2272730 [TBL] [Abstract][Full Text] [Related]
18. Modification of immunostimulating activities of grifolan by the treatment with (1----3)-beta-D-glucanase. Nono I; Ohno N; Ohsawa M; Oikawa S; Yadomae T J Pharmacobiodyn; 1989 Nov; 12(11):671-80. PubMed ID: 2632764 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of the beta-glucan receptor of murine macrophages. Goldman R Exp Cell Res; 1988 Feb; 174(2):481-90. PubMed ID: 2828085 [TBL] [Abstract][Full Text] [Related]
20. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]